INCY  valuation analysis

Name: Incyte Corporation
Description: Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. (more)
Industry: Biotechnology
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: May 04, 2021
Market cap: $17.59B (366th)
Sales(TTM): $2.70B (659th)
Earnings(TTM): $328.78M (508th)

FFER: 1.30*
Actual price: $79.99
* Earnings were reported Aug 02, 2021 but we do not have the financials for this quarter. This is likely because the company has not yet released them. However, it might also be a problem with data quality. Regardless, you should take the FFER above with a grain of salt until we get updated financials.

Prices as of EOD 2021-07-15
Price & Estimates
Sales & Earnings history (TTM)
  • Incyte Corporation's earnings increased from -$376.05M to $328.78M in the last year.
  • Incyte Corporation's operating income increased from -$316.38M to $353.72M in the last year.
Earnings / MarketCap
Incyte Corporation
"Biotechnology" industry
Sales / MarketCap
Incyte Corporation
"Biotechnology" industry
Book / MarketCap
Incyte Corporation
"Biotechnology" industry
Equity / Assets
Incyte Corporation
"Biotechnology" industry